ID   INO1_RAT                Reviewed;         557 AA.
AC   Q6AYK3;
DT   18-MAR-2008, integrated into UniProtKB/Swiss-Prot.
DT   18-MAR-2008, sequence version 2.
DT   29-MAY-2024, entry version 123.
DE   RecName: Full=Inositol-3-phosphate synthase 1;
DE            Short=IPS 1;
DE            EC=5.5.1.4 {ECO:0000269|PubMed:19188364, ECO:0000269|PubMed:23504145, ECO:0000269|PubMed:6773943, ECO:0000269|PubMed:885873};
DE   AltName: Full=Myo-inositol 1-phosphate synthase;
DE            Short=MI-1-P synthase;
DE            Short=MIP synthase;
GN   Name=Isyna1; Synonyms=Ino1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [2]
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, AND TISSUE SPECIFICITY.
RX   PubMed=885873; DOI=10.1016/s0021-9258(17)40075-5;
RA   Sherman W.R., Rasheed A., Mauck L.A., Wiecko J.;
RT   "Incubations of testis myo-inositol-1-phosphate synthase with D-(5-
RT   18O)glucose 6-phosphate and with H218O show no evidence of Schiff base
RT   formation.";
RL   J. Biol. Chem. 252:5672-5676(1977).
RN   [3]
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, BIOPHYSICOCHEMICAL PROPERTIES,
RP   ACTIVITY REGULATION, SUBUNIT, AND TISSUE SPECIFICITY.
RX   PubMed=6773943; DOI=10.1016/s0021-9258(18)43518-1;
RA   Maeda T., Eisenberg F. Jr.;
RT   "Purification, structure, and catalytic properties of L-myo-inositol-1-
RT   phosphate synthase from rat testis.";
RL   J. Biol. Chem. 255:8458-8464(1980).
RN   [4]
RP   FUNCTION (ISOFORMS 1 AND 2), CATALYTIC ACTIVITY (ISOFORM 1), COFACTOR
RP   (ISOFORMS 1 AND 2), ALTERNATIVE SPLICING, IDENTIFICATION BY MASS
RP   SPECTROMETRY, AND TISSUE SPECIFICITY (ISOFORMS 1; 2 AND 3).
RX   PubMed=19188364; DOI=10.1074/jbc.m900206200;
RA   Seelan R.S., Lakshmanan J., Casanova M.F., Parthasarathy R.N.;
RT   "Identification of myo-inositol-3-phosphate synthase isoforms:
RT   characterization, expression, and putative role of a 16-kDa gamma(c)
RT   isoform.";
RL   J. Biol. Chem. 284:9443-9457(2009).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, TISSUE SPECIFICITY (ISOFORM 3),
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND PHOSPHORYLATION AT SER-524.
RX   PubMed=23504145; DOI=10.1007/s11010-013-1597-7;
RA   Parthasarathy R.N., Lakshmanan J., Thangavel M., Seelan R.S., Stagner J.I.,
RA   Janckila A.J., Vadnal R.E., Casanova M.F., Parthasarathy L.K.;
RT   "Rat brain myo-inositol 3-phosphate synthase is a phosphoprotein.";
RL   Mol. Cell. Biochem. 378:83-89(2013).
CC   -!- FUNCTION: Key enzyme in myo-inositol biosynthesis pathway that
CC       catalyzes the conversion of glucose 6-phosphate to 1-myo-inositol 1-
CC       phosphate in a NAD-dependent manner (PubMed:23504145, PubMed:6773943,
CC       PubMed:885873). Rate-limiting enzyme in the synthesis of all inositol-
CC       containing compounds (By similarity). {ECO:0000250|UniProtKB:Q9NPH2,
CC       ECO:0000269|PubMed:23504145, ECO:0000269|PubMed:6773943,
CC       ECO:0000269|PubMed:885873}.
CC   -!- FUNCTION: [Isoform 1]: Key enzyme in myo-inositol biosynthesis pathway
CC       that catalyzes the conversion of glucose 6-phosphate to 1-myo-inositol
CC       1-phosphate in a NAD-dependent manner. {ECO:0000269|PubMed:19188364}.
CC   -!- FUNCTION: [Isoform 2]: Competitively inhibits the function of isoform
CC       1, presumably by competing for NAD cofactor.
CC       {ECO:0000269|PubMed:19188364}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=D-glucose 6-phosphate = 1D-myo-inositol 3-phosphate;
CC         Xref=Rhea:RHEA:10716, ChEBI:CHEBI:58401, ChEBI:CHEBI:61548;
CC         EC=5.5.1.4; Evidence={ECO:0000269|PubMed:23504145,
CC         ECO:0000269|PubMed:6773943, ECO:0000269|PubMed:885873};
CC   -!- CATALYTIC ACTIVITY: [Isoform 1]:
CC       Reaction=D-glucose 6-phosphate = 1D-myo-inositol 3-phosphate;
CC         Xref=Rhea:RHEA:10716, ChEBI:CHEBI:58401, ChEBI:CHEBI:61548;
CC         EC=5.5.1.4; Evidence={ECO:0000269|PubMed:19188364};
CC   -!- COFACTOR:
CC       Name=NAD(+); Xref=ChEBI:CHEBI:57540;
CC         Evidence={ECO:0000269|PubMed:6773943, ECO:0000269|PubMed:885873};
CC   -!- COFACTOR: [Isoform 1]:
CC       Name=NAD(+); Xref=ChEBI:CHEBI:57540;
CC         Evidence={ECO:0000269|PubMed:19188364};
CC   -!- COFACTOR: [Isoform 2]:
CC       Name=NAD(+); Xref=ChEBI:CHEBI:57540;
CC         Evidence={ECO:0000269|PubMed:19188364};
CC   -!- ACTIVITY REGULATION: Inhibited by 2-deoxyglucitol 6-phosphate (dgtolP)
CC       and 2-deoxy-D-glucose 6-phosphate (PubMed:6773943). Inhibited by
CC       copper, mercury, cadmium, zinc and copper ions (PubMed:6773943).
CC       Activated by potassium and ammonium ions (PubMed:6773943).
CC       {ECO:0000269|PubMed:6773943}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=3.89 mM for D-glucose 6-phosphate (at pH 7.4 and 37 degrees
CC         Celsius) {ECO:0000269|PubMed:6773943};
CC       pH dependence:
CC         Optimum pH is 7.7. {ECO:0000269|PubMed:6773943};
CC   -!- PATHWAY: Polyol metabolism; myo-inositol biosynthesis; myo-inositol
CC       from D-glucose 6-phosphate: step 1/2.
CC   -!- SUBUNIT: Homotrimer. {ECO:0000269|PubMed:6773943}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P11986}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=alpha {ECO:0000303|PubMed:19188364};
CC         IsoId=Q6AYK3-1; Sequence=Displayed;
CC       Name=2; Synonyms=gammac {ECO:0000303|PubMed:19188364};
CC         IsoId=Q6AYK3-3; Sequence=VSP_061662;
CC       Name=3;
CC         IsoId=Q6AYK3-5; Sequence=VSP_061663;
CC   -!- TISSUE SPECIFICITY: Expressed in testis, brain and epididymis (at
CC       protein level) (PubMed:19188364, PubMed:23504145, PubMed:6773943,
CC       PubMed:885873). Moderately expressed in brain, lung, liver, and kidney
CC       (PubMed:19188364). Low expression in heart and spleen
CC       (PubMed:19188364). Very low expression in skeletal muscle
CC       (PubMed:19188364). {ECO:0000269|PubMed:19188364,
CC       ECO:0000269|PubMed:23504145, ECO:0000269|PubMed:6773943,
CC       ECO:0000269|PubMed:885873}.
CC   -!- TISSUE SPECIFICITY: [Isoform 1]: Expressed in testis, spleen, heart,
CC       brainstem, hippocampus, cerebellum, cortex and amygdala
CC       (PubMed:19188364). Absent or very lowly expressed in intestine, lung
CC       and muscle (PubMed:19188364). {ECO:0000269|PubMed:19188364}.
CC   -!- TISSUE SPECIFICITY: [Isoform 2]: Expressed in intestine, lung, liver,
CC       muscle, testis, spleen, brainstem, hippocampus, cerebellum, cortex and
CC       amygdala (PubMed:19188364). Absent or lowly expressed in heart and
CC       kidney (PubMed:19188364). {ECO:0000269|PubMed:19188364}.
CC   -!- TISSUE SPECIFICITY: [Isoform 3]: Expressed in intestine (at protein
CC       level). {ECO:0000269|PubMed:19188364, ECO:0000269|PubMed:23504145}.
CC   -!- PTM: Phosphorylation at Ser-524 does not appear to affect enzyme
CC       activity, and is detected in brain and testis.
CC       {ECO:0000269|PubMed:23504145}.
CC   -!- SIMILARITY: Belongs to the myo-inositol 1-phosphate synthase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AABR03100304; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001013902.2; NM_001013880.2. [Q6AYK3-1]
DR   AlphaFoldDB; Q6AYK3; -.
DR   SMR; Q6AYK3; -.
DR   BioGRID; 253271; 1.
DR   STRING; 10116.ENSRNOP00000026821; -.
DR   iPTMnet; Q6AYK3; -.
DR   PhosphoSitePlus; Q6AYK3; -.
DR   SwissPalm; Q6AYK3; -.
DR   PaxDb; 10116-ENSRNOP00000026821; -.
DR   Ensembl; ENSRNOT00000026821.6; ENSRNOP00000026821.3; ENSRNOG00000019741.6. [Q6AYK3-1]
DR   Ensembl; ENSRNOT00055017525; ENSRNOP00055014121; ENSRNOG00055010351. [Q6AYK3-1]
DR   Ensembl; ENSRNOT00060015808; ENSRNOP00060012336; ENSRNOG00060009375. [Q6AYK3-1]
DR   Ensembl; ENSRNOT00065039218; ENSRNOP00065031857; ENSRNOG00065022942. [Q6AYK3-1]
DR   GeneID; 290651; -.
DR   KEGG; rno:290651; -.
DR   UCSC; RGD:1359423; rat. [Q6AYK3-1]
DR   AGR; RGD:1359423; -.
DR   CTD; 51477; -.
DR   RGD; 1359423; Isyna1.
DR   eggNOG; KOG0693; Eukaryota.
DR   GeneTree; ENSGT00390000018395; -.
DR   HOGENOM; CLU_021486_2_0_1; -.
DR   InParanoid; Q6AYK3; -.
DR   OMA; VPKVGMM; -.
DR   OrthoDB; 1201882at2759; -.
DR   PhylomeDB; Q6AYK3; -.
DR   TreeFam; TF300382; -.
DR   BRENDA; 5.5.1.4; 5301.
DR   Reactome; R-RNO-1855183; Synthesis of IP2, IP, and Ins in the cytosol.
DR   SABIO-RK; Q6AYK3; -.
DR   UniPathway; UPA00823; UER00787.
DR   PRO; PR:Q6AYK3; -.
DR   Proteomes; UP000002494; Chromosome 16.
DR   Bgee; ENSRNOG00000019741; Expressed in ovary and 20 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0004512; F:inositol-3-phosphate synthase activity; IDA:UniProtKB.
DR   GO; GO:0006021; P:inositol biosynthetic process; IDA:UniProtKB.
DR   GO; GO:1900089; P:negative regulation of inositol biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0008654; P:phospholipid biosynthetic process; IEA:UniProtKB-KW.
DR   Gene3D; 3.40.50.720; NAD(P)-binding Rossmann-like Domain; 2.
DR   InterPro; IPR002587; Myo-inos-1-P_Synthase.
DR   InterPro; IPR013021; Myo-inos-1-P_Synthase_GAPDH.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   PANTHER; PTHR11510:SF5; INOSITOL-3-PHOSPHATE SYNTHASE 1; 1.
DR   PANTHER; PTHR11510; MYO-INOSITOL-1 PHOSPHATE SYNTHASE; 1.
DR   Pfam; PF01658; Inos-1-P_synth; 1.
DR   Pfam; PF07994; NAD_binding_5; 1.
DR   PIRSF; PIRSF015578; Myoinos-ppht_syn; 1.
DR   SUPFAM; SSF55347; Glyceraldehyde-3-phosphate dehydrogenase-like, C-terminal domain; 1.
DR   SUPFAM; SSF51735; NAD(P)-binding Rossmann-fold domains; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cytoplasm; Inositol biosynthesis; Isomerase;
KW   Lipid biosynthesis; Lipid metabolism; NAD; Phospholipid biosynthesis;
KW   Phospholipid metabolism; Phosphoprotein; Reference proteome.
FT   CHAIN           1..557
FT                   /note="Inositol-3-phosphate synthase 1"
FT                   /id="PRO_0000324631"
FT   REGION          514..557
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        529..557
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         67
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P11986"
FT   BINDING         68
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P11986"
FT   BINDING         69
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P11986"
FT   BINDING         70
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P11986"
FT   BINDING         141
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P11986"
FT   BINDING         177
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P11986"
FT   BINDING         178
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P11986"
FT   BINDING         188
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P11986"
FT   BINDING         191
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P11986"
FT   BINDING         228
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P11986"
FT   BINDING         229
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P11986"
FT   BINDING         230
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P11986"
FT   BINDING         231
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P11986"
FT   BINDING         278
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P11986"
FT   BINDING         279
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P11986"
FT   BINDING         303
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P11986"
FT   BINDING         306
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P11986"
FT   BINDING         337
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P11986"
FT   BINDING         338
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P11986"
FT   BINDING         339
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P11986"
FT   BINDING         352
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P11986"
FT   BINDING         390
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P11986"
FT   BINDING         391
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P11986"
FT   BINDING         419
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P11986"
FT   BINDING         420
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P11986"
FT   MOD_RES         279
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NPH2"
FT   MOD_RES         357
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NPH2"
FT   MOD_RES         524
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:23504145"
FT   VAR_SEQ         139..557
FT                   /note="GWDISSLNLAEAMRRAQVLDCGLQEQLWPHMESLRPRPSVYIPEFIAANQTA
FT                   RADNLIPGTRAQQLEQIRKDIRDFRSSAGLDKVIVLWTANTERFCEVVPGRNDTAENLL
FT                   RTIQLGLEVSPSTLFAVASILEGCAFLNGSPQNTLVPGALELASQRHVFVGGDDFKSGQ
FT                   TKVKSVLVDFLIGSGLKTMSIVSYNHLGNNDGQNLSAPLQFRSKEVTKSSVVDDMVQSN
FT                   RVLYAPGEEPDHCVVIKYVPYVGDSKRALDEYTSELMLGGTNTLVLHNTCEDSLLAAPI
FT                   MLDLVLLTELCQRVSFCTDSDPEPQGFHPVLSVLSFLFKAPLVPPGSPVVNALFRQRSC
FT                   IENIFRACVGLPPQNHMLLEHKMERPFPGIKPEEVKATSPLPCKKESTPATNGCTGDAN
FT                   GHTQAPTPELSTA -> GGQSLGMGWG (in isoform 2)"
FT                   /evidence="ECO:0000269|PubMed:19188364"
FT                   /id="VSP_061662"
FT   VAR_SEQ         492..557
FT                   /note="Missing (in isoform 3)"
FT                   /id="VSP_061663"
SQ   SEQUENCE   557 AA;  60884 MW;  F351B16D74E94281 CRC64;
     MEPAAEILVD SPDVIFGPEA IEARYEYRTT RVSREGGVLR VRPTATRFTF RTARQVPRLG
     VMLVGWGGNN GSTLTAAVLA NRLRLTWPTR TGRKEANYYG SLTQAGTVNL GLDGDGREVF
     VPFSALLPMV APNDLVFDGW DISSLNLAEA MRRAQVLDCG LQEQLWPHME SLRPRPSVYI
     PEFIAANQTA RADNLIPGTR AQQLEQIRKD IRDFRSSAGL DKVIVLWTAN TERFCEVVPG
     RNDTAENLLR TIQLGLEVSP STLFAVASIL EGCAFLNGSP QNTLVPGALE LASQRHVFVG
     GDDFKSGQTK VKSVLVDFLI GSGLKTMSIV SYNHLGNNDG QNLSAPLQFR SKEVTKSSVV
     DDMVQSNRVL YAPGEEPDHC VVIKYVPYVG DSKRALDEYT SELMLGGTNT LVLHNTCEDS
     LLAAPIMLDL VLLTELCQRV SFCTDSDPEP QGFHPVLSVL SFLFKAPLVP PGSPVVNALF
     RQRSCIENIF RACVGLPPQN HMLLEHKMER PFPGIKPEEV KATSPLPCKK ESTPATNGCT
     GDANGHTQAP TPELSTA
//
